Protagenic Therapeutics, Inc. announced that at the Annual Meeting of Stockholders held on November 23, 2022 approved the election of Timothy R. Wright as a Class I director to serve their terms until the Company's 2025 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 USD | -4.02% | -15.57% | +42.42% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+42.42% | 6.52M | |
+52.36% | 56.69B | |
-3.86% | 41B | |
+38.14% | 38.11B | |
-12.01% | 26.89B | |
+14.13% | 25.59B | |
-21.62% | 18.59B | |
+0.21% | 12.39B | |
+25.96% | 11.99B | |
+23.02% | 11.88B |
- Stock Market
- Equities
- PTIX Stock
- News Protagenic Therapeutics, Inc.
- Protagenic Therapeutics, Inc. Appoints Timothy R. Wright as a Class I Director